Railroads
Compare Stocks
5 / 10Stock Comparison
WAB vs RXO vs TT vs CHRW vs CARR
Revenue, margins, valuation, and 5-year total return — side by side.
Trucking
Construction
Integrated Freight & Logistics
Construction
WAB vs RXO vs TT vs CHRW vs CARR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Railroads | Trucking | Construction | Integrated Freight & Logistics | Construction |
| Market Cap | $45.08B | $3.58B | $103.18B | $20.33B | $55.83B |
| Revenue (TTM) | $11.51B | $4.31B | $21.60B | $16.20B | $21.87B |
| Net Income (TTM) | $1.21B | $-69M | $2.90B | $599M | $1.32B |
| Gross Margin | 33.8% | 17.5% | 35.9% | 8.3% | 24.8% |
| Operating Margin | 16.1% | -0.2% | 18.2% | 4.9% | 8.1% |
| Forward P/E | 25.0x | 1250.0x | 31.3x | 27.8x | 23.9x |
| Total Debt | $5.54B | $861M | $4.62B | $1.63B | $12.67B |
| Cash & Equiv. | $789M | $18M | $1.76B | $161M | $1.55B |
WAB vs RXO vs TT vs CHRW vs CARR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 22 | May 26 | Return |
|---|---|---|---|
| Westinghouse Air Br… (WAB) | 100 | 284.9 | +184.9% |
| RXO, Inc. (RXO) | 100 | 103.6 | +3.6% |
| Trane Technologies … (TT) | 100 | 292.0 | +192.0% |
| C.H. Robinson World… (CHRW) | 100 | 175.4 | +75.4% |
| Carrier Global Corp… (CARR) | 100 | 168.1 | +68.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WAB vs RXO vs TT vs CHRW vs CARR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WAB ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.97 vs CHRW's 5.19
- Lower P/E (25.0x vs 31.3x), PEG 0.97 vs 1.05
RXO is the clearest fit if your priority is growth exposure.
- Rev growth 26.2%, EPS growth 72.8%, 3Y rev CAGR 6.2%
- 26.2% revenue growth vs CHRW's -8.4%
TT is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 8.7% 10Y total return vs WAB's 247.1%
- 13.4% margin vs RXO's -1.6%
- 13.4% ROA vs RXO's -2.1%, ROIC 26.2% vs -0.2%
CHRW carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 5 yrs, beta 0.97, yield 1.4%
- Lower volatility, beta 0.97, Low D/E 88.3%, current ratio 1.53x
- Beta 0.97, yield 1.4%, current ratio 1.53x
- Beta 0.97 vs RXO's 2.66
Among these 5 stocks, CARR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% revenue growth vs CHRW's -8.4% | |
| Value | Lower P/E (25.0x vs 31.3x), PEG 0.97 vs 1.05 | |
| Quality / Margins | 13.4% margin vs RXO's -1.6% | |
| Stability / Safety | Beta 0.97 vs RXO's 2.66 | |
| Dividends | 1.4% yield, 5-year raise streak, vs CARR's 1.4%, (1 stock pays no dividend) | |
| Momentum (1Y) | +94.1% vs CARR's -3.9% | |
| Efficiency (ROA) | 13.4% ROA vs RXO's -2.1%, ROIC 26.2% vs -0.2% |
WAB vs RXO vs TT vs CHRW vs CARR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WAB vs RXO vs TT vs CHRW vs CARR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TT leads in 2 of 6 categories
RXO leads 1 • WAB leads 1 • CHRW leads 0 • CARR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CARR is the larger business by revenue, generating $21.9B annually — 5.1x RXO's $4.3B. TT is the more profitable business, keeping 13.4% of every revenue dollar as net income compared to RXO's -1.6%. On growth, WAB holds the edge at +13.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11.5B | $4.3B | $21.6B | $16.2B | $21.9B |
| EBITDAEarnings before interest/tax | $2.3B | $77M | $4.3B | $896M | $3.1B |
| Net IncomeAfter-tax profit | $1.2B | -$69M | $2.9B | $599M | $1.3B |
| Free Cash FlowCash after capex | $1.6B | -$15M | $3.2B | $858M | $1.7B |
| Gross MarginGross profit ÷ Revenue | +33.8% | +17.5% | +35.9% | +8.3% | +24.8% |
| Operating MarginEBIT ÷ Revenue | +16.1% | -0.2% | +18.2% | +4.9% | +8.1% |
| Net MarginNet income ÷ Revenue | +10.5% | -1.6% | +13.4% | +3.7% | +6.0% |
| FCF MarginFCF ÷ Revenue | +14.3% | -0.3% | +14.6% | +5.3% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.0% | -99.9% | +6.0% | -0.8% | +2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.8% | -16.7% | -1.9% | +9.9% | -40.4% |
Valuation Metrics
RXO leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 35.5x trailing earnings, CHRW trades at a 10% valuation discount to CARR's 39.3x P/E. Adjusting for growth (PEG ratio), TT offers better value at 1.20x vs CHRW's 6.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45.1B | $3.6B | $103.2B | $20.3B | $55.8B |
| Enterprise ValueMkt cap + debt − cash | $49.8B | $4.4B | $106.0B | $21.8B | $66.9B |
| Trailing P/EPrice ÷ TTM EPS | 38.90x | -36.86x | 35.91x | 35.48x | 39.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.05x | 1250.00x | 31.29x | 27.83x | 23.95x |
| PEG RatioP/E ÷ EPS growth rate | 1.51x | — | 1.20x | 6.62x | — |
| EV / EBITDAEnterprise value multiple | 21.03x | 40.60x | 25.06x | 24.28x | 21.63x |
| Price / SalesMarket cap ÷ Revenue | 4.04x | 0.62x | 4.84x | 1.25x | 2.57x |
| Price / BookPrice ÷ Book value/share | 4.06x | 2.38x | 12.12x | 11.28x | 4.01x |
| Price / FCFMarket cap ÷ FCF | 30.08x | — | 36.70x | 22.72x | 32.90x |
Profitability & Efficiency
TT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
TT delivers a 34.7% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $-4 for RXO. WAB carries lower financial leverage with a 0.50x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARR's 0.90x. On the Piotroski fundamental quality scale (0–9), TT scores 9/9 vs CARR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.9% | -4.4% | +34.7% | +33.3% | +9.1% |
| ROA (TTM)Return on assets | +5.6% | -2.1% | +13.4% | +11.5% | +3.5% |
| ROICReturn on invested capital | +9.6% | -0.2% | +26.2% | +18.0% | +6.7% |
| ROCEReturn on capital employed | +11.7% | -0.3% | +27.2% | +25.6% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.50x | 0.56x | 0.54x | 0.88x | 0.90x |
| Net DebtTotal debt minus cash | $4.8B | $843M | $2.9B | $1.5B | $11.1B |
| Cash & Equiv.Liquid assets | $789M | $18M | $1.8B | $161M | $1.6B |
| Total DebtShort + long-term debt | $5.5B | $861M | $4.6B | $1.6B | $12.7B |
| Interest CoverageEBIT ÷ Interest expense | 7.41x | -3.15x | 17.21x | 6.27x | 5.76x |
Total Returns (Dividends Reinvested)
WAB leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WAB five years ago would be worth $33,309 today (with dividends reinvested), compared to $10,357 for RXO. Over the past 12 months, CHRW leads with a +94.1% total return vs CARR's -3.9%. The 3-year compound annual growth rate (CAGR) favors WAB at 39.3% vs RXO's 4.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.0% | +69.4% | +17.4% | +5.1% | +25.8% |
| 1-Year ReturnPast 12 months | +39.1% | +50.7% | +15.9% | +94.1% | -3.9% |
| 3-Year ReturnCumulative with dividends | +170.1% | +12.4% | +169.6% | +73.7% | +62.8% |
| 5-Year ReturnCumulative with dividends | +233.1% | +3.6% | +158.1% | +80.1% | +55.4% |
| 10-Year ReturnCumulative with dividends | +247.1% | +3.6% | +867.6% | +163.6% | +491.3% |
| CAGR (3Y)Annualised 3-year return | +39.3% | +4.0% | +39.2% | +20.2% | +17.6% |
Risk & Volatility
Evenly matched — WAB and CHRW each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHRW is the less volatile stock with a 0.97 beta — it tends to amplify market swings less than RXO's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAB currently trades 96.3% from its 52-week high vs CARR's 82.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.11x | 2.66x | 0.98x | 0.97x | 1.21x |
| 52-Week HighHighest price in past year | $275.84 | $23.37 | $503.47 | $203.34 | $81.09 |
| 52-Week LowLowest price in past year | $184.26 | $10.43 | $348.06 | $87.41 | $50.24 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +93.1% | +92.6% | +84.3% | +82.4% |
| RSI (14)Momentum oscillator 0–100 | 53.8 | 74.6 | 50.5 | 45.9 | 61.7 |
| Avg Volume (50D)Average daily shares traded | 902K | 1.9M | 1.2M | 1.7M | 6.6M |
Analyst Outlook
Evenly matched — WAB and CHRW and CARR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WAB as "Buy", RXO as "Hold", TT as "Hold", CHRW as "Hold", CARR as "Buy". Consensus price targets imply 12.1% upside for TT (target: $523) vs -10.3% for RXO (target: $20). For income investors, CHRW offers the higher dividend yield at 1.45% vs WAB's 0.38%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $291.00 | $19.50 | $522.73 | $187.38 | $67.50 |
| # AnalystsCovering analysts | 34 | 20 | 26 | 46 | 26 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | — | +0.8% | +1.4% | +1.4% |
| Dividend StreakConsecutive years of raises | 6 | — | 5 | 5 | 6 |
| Dividend / ShareAnnual DPS | $1.01 | — | $3.74 | $2.48 | $0.91 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +0.0% | +1.4% | +1.7% | +5.2% |
TT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RXO leads in 1 (Valuation Metrics). 2 tied.
WAB vs RXO vs TT vs CHRW vs CARR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WAB or RXO or TT or CHRW or CARR a better buy right now?
For growth investors, RXO, Inc.
(RXO) is the stronger pick with 26. 2% revenue growth year-over-year, versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). C. H. Robinson Worldwide, Inc. (CHRW) offers the better valuation at 35. 5x trailing P/E (27. 8x forward), making it the more compelling value choice. Analysts rate Westinghouse Air Brake Technologies Corporation (WAB) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WAB or RXO or TT or CHRW or CARR?
On trailing P/E, C.
H. Robinson Worldwide, Inc. (CHRW) is the cheapest at 35. 5x versus Carrier Global Corporation at 39. 3x. On forward P/E, Carrier Global Corporation is actually cheaper at 23. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Westinghouse Air Brake Technologies Corporation wins at 0. 97x versus C. H. Robinson Worldwide, Inc. 's 5. 19x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — WAB or RXO or TT or CHRW or CARR?
Over the past 5 years, Westinghouse Air Brake Technologies Corporation (WAB) delivered a total return of +233.
1%, compared to +3. 6% for RXO, Inc. (RXO). Over 10 years, the gap is even starker: TT returned +867. 6% versus RXO's +3. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WAB or RXO or TT or CHRW or CARR?
By beta (market sensitivity over 5 years), C.
H. Robinson Worldwide, Inc. (CHRW) is the lower-risk stock at 0. 97β versus RXO, Inc. 's 2. 66β — meaning RXO is approximately 174% more volatile than CHRW relative to the S&P 500. On balance sheet safety, Westinghouse Air Brake Technologies Corporation (WAB) carries a lower debt/equity ratio of 50% versus 90% for Carrier Global Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — WAB or RXO or TT or CHRW or CARR?
By revenue growth (latest reported year), RXO, Inc.
(RXO) is pulling ahead at 26. 2% versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). On earnings-per-share growth, the picture is similar: RXO, Inc. grew EPS 72. 8% year-over-year, compared to -72. 4% for Carrier Global Corporation. Over a 3-year CAGR, WAB leads at 10. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WAB or RXO or TT or CHRW or CARR?
Trane Technologies plc (TT) is the more profitable company, earning 13.
7% net margin versus -1. 7% for RXO, Inc. — meaning it keeps 13. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TT leads at 18. 6% versus -0. 1% for RXO. At the gross margin level — before operating expenses — TT leads at 36. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WAB or RXO or TT or CHRW or CARR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Westinghouse Air Brake Technologies Corporation (WAB) is the more undervalued stock at a PEG of 0. 97x versus C. H. Robinson Worldwide, Inc. 's 5. 19x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carrier Global Corporation (CARR) trades at 23. 9x forward P/E versus 1250. 0x for RXO, Inc. — 1226. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TT: 12. 1% to $522. 73.
08Which pays a better dividend — WAB or RXO or TT or CHRW or CARR?
In this comparison, CHRW (1.
4% yield), CARR (1. 4% yield), TT (0. 8% yield), WAB (0. 4% yield) pay a dividend. RXO does not pay a meaningful dividend and should not be held primarily for income.
09Is WAB or RXO or TT or CHRW or CARR better for a retirement portfolio?
For long-horizon retirement investors, Trane Technologies plc (TT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
98), 0. 8% yield, +867. 6% 10Y return). RXO, Inc. (RXO) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TT: +867. 6%, RXO: +3. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WAB and RXO and TT and CHRW and CARR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: WAB is a mid-cap quality compounder stock; RXO is a small-cap high-growth stock; TT is a mid-cap quality compounder stock; CHRW is a mid-cap quality compounder stock; CARR is a mid-cap quality compounder stock. TT, CHRW, CARR pay a dividend while WAB, RXO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.